Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
- PMID:17805350
- DOI: 10.1038/sj.jid.5701033
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe cutaneous adverse reactions (SCAR) related to a variety of medications. They have a significant public health impact because of high mortality and morbidity. A multinational case-control study conducted in Europe between 1997 and 2001 evaluated the risk of medications to induce SCAR. Cases were actively detected through a hospital network covering more than 100 million inhabitants. Three hospitalized patients per case matched on age, gender, and date of interview were enrolled as controls. After validation by an expert committee blinded to exposures, 379 SCAR cases and 1,505 controls were included. Among drugs recently introduced into the market, strong associations were documented for nevirapine (relative risk (RR)>22) and lamotrigine (RR>14), and weaker associations for sertraline (RR=11 [2.7-46]), pantoprazole (RR=18 [3.9-85]), and tramadol (RR=20 [4.4-93]). Strong associations were confirmed for anti-infective sulfonamides, allopurinol, carbamazapine, phenobarbital, phenytoin, and oxicam-NSAIDs , with some changes in relative numbers of exposed cases. Thus, many cases were still related to a few "old" drugs with a known high risk. Risk was restricted to the first few weeks of drug intake. The use of such drugs as first-line therapies should be considered carefully, especially when safer alternative treatments exist. A number of widely used drugs did not show any risk for SJS and TEN.
Similar articles
- Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, et al.Roujeau JC, et al.N Engl J Med. 1995 Dec 14;333(24):1600-7. doi: 10.1056/NEJM199512143332404.N Engl J Med. 1995.PMID:7477195
- Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.Levi N, et al.Pediatrics. 2009 Feb;123(2):e297-304. doi: 10.1542/peds.2008-1923. Epub 2009 Jan 19.Pediatrics. 2009.PMID:19153164
- A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M; RegiSCAR study group.Lonjou C, et al.Pharmacogenet Genomics. 2008 Feb;18(2):99-107. doi: 10.1097/FPC.0b013e3282f3ef9c.Pharmacogenet Genomics. 2008.PMID:18192896
- [Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk].Gómez-Criado MS, Ayani I, León-Colombo T, Ramos ML, Reneses MJ.Gómez-Criado MS, et al.Rev Neurol. 2004 Jun 1-15;38(11):1056-60.Rev Neurol. 2004.PMID:15202085Review.Spanish.
- [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].Halevy S.Halevy S.Harefuah. 2010 Mar;149(3):186-90, 193.Harefuah. 2010.PMID:20684173Review.Hebrew.
Cited by
- A pilot study on the incidence of severe photosensitivity reactions leading to hospitalization linked to topical ketoprofen and other medications in selected European regions.Cazzaniga S, Naldi L, Lecchi S, Kürzinger ML, Auclert L, Gori M, Chosidow O, Hercogova J.Cazzaniga S, et al.Pharmacol Res Perspect. 2016 Apr 27;4(3):e00225. doi: 10.1002/prp2.225. eCollection 2016 Jun.Pharmacol Res Perspect. 2016.PMID:27433339Free PMC article.
- Stevens-johnson syndrome induced by carbamazepine treatment in a patient who previously had carbamazepine induced pruritus - a case report -.Bae HM, Park YJ, Kim YH, Moon DE.Bae HM, et al.Korean J Pain. 2013 Jan;26(1):80-3. doi: 10.3344/kjp.2013.26.1.80. Epub 2013 Jan 4.Korean J Pain. 2013.PMID:23342214Free PMC article.
- Cephazolin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin and N-acetylcysteine.Saavedra C, Cárdenas P, Castellanos H, Contreras K, Castro JR.Saavedra C, et al.Case Reports Immunol. 2012;2012:931528. doi: 10.1155/2012/931528. Epub 2012 Apr 19.Case Reports Immunol. 2012.PMID:25954556Free PMC article.
- Toxic epidermal necrolysis: a retrospective analysis of 17 cases from central Tunisia.Ben Salem C, Badreddine A, Belajouza O, Belajouza C, Ghariani N, Houssem H.Ben Salem C, et al.Pan Afr Med J. 2014 Nov 11;19:269. doi: 10.11604/pamj.2014.19.269.3987. eCollection 2014.Pan Afr Med J. 2014.PMID:25870724Free PMC article.
- Stevens-Johnson Syndrome triggered by a combination of clobazam, lamotrigine and valproic acid in a 7-year-old child.Yapici AK, Fidanci MK, Kilic S, Balamtekin N, Mutluay Arslan M, Yavuz ST, Kalman S.Yapici AK, et al.Ann Burns Fire Disasters. 2014 Sep 30;27(3):121-5.Ann Burns Fire Disasters. 2014.PMID:26170788Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources